PASITHEA THERAPEUTICS CORP. (KTTAW) Capital expenditures 2022–2024
PASITHEA THERAPEUTICS CORP. (KTTAW) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$34,301FY2024 · since FY2022: $21,503 → $34,301
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $34,301 | -68.0% |
| FY2023 | $107,101 | +398.1% |
| FY2022 | $21,503 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice